Paul Mampilly has made a fortune for many people by detecting and riding technological trends. Now he has identified a megatrend in medicine that is going to radically transform how doctors treat patients with such difficult illnesses as heart disease, Parkinson’s, Alzheimer’s, cancer and arthritis. Doctors rarely admitted this to patients, but when they prescribed medicine and other treatments for such diseases, they have really been throwing it against the wall, hoping something would stick. See, medicines, surgeries and other treatments have been proven to help patients, or the Food and Drug Administration would not approve them. But no medicine or other treatment has a 100% effectiveness record. While some patients get better, others don’t. And doctors didn’t know why. And they had no way of determining in advance what patients would respond well to a prescription drug and which patients for whom it was a pointless waste of time.
However, the mapping of the humane genome has helped scientists to understand that the genetic basis of these diseases is different in people, because every has a unique genome. The increasing ability of modern medicine to design a therapy for each individual patient is called precision medicine. It’s going to save a lot of money and it’s going to help solve and manage the toughest diseases. In the future, there will be no one size fits all medications.
Mampilly’s research has uncovered a small biotech firm that is at the forefront of this revolution in precision medicine. In a recent free report, he explains just how precision medicine is such a historic breakthrough that is going to make healthcare so much more effective. And how this company is bought to make tremendous profits in the years ahead. That means it’s stock price is bound to grow, making investors who buy it today wealthy. They are the leader in the field of genetic screening for various diseases, especially cancer.
Paul Mampilly says this company is just another example of how he has learned from his father. His father grew up desperately poor in India, but managed to put himself through college. Even after taking a good job, his father still could barely feed his family. One day he read that oil was discovered in Dubai, so he took a job in that country with the hope it would provide him with more opportunity than India. His calculated risk paid off, and so his son Paul Mampilly learned the value of taking chances when the odds are in your favor.
About Paul Mampilly: banyanhill.com/expert/paul-mampilly/